KRAS mutation leads to decreased expression of regulator of calcineurin 2, resulting in tumor proliferation in colorectal cancer.
Niitsu H, Hinoi T, Kawaguchi Y, Sentani K, Yuge R, Kitadai Y, Sotomaru Y, Adachi T, Saito Y, Miguchi M, Kochi M, Sada H, Shimomura M, Oue N, Yasui W, Ohdan H.
Niitsu H, et al. Among authors: yuge r.
Oncogenesis. 2016 Aug 15;5(8):e253. doi: 10.1038/oncsis.2016.47.
Oncogenesis. 2016.
PMID: 27526107
Free PMC article.